Mississippi House Bill HB1317

Mississippi 2023 Regular Session

• Introduced: 1/16/23
• Refer: 1/16/23

Caption

Pharmacists; authorize to test for and administer treatment for minor, nonchronic health conditions.

Impact

If passed, this bill significantly modifies the legal framework surrounding the practice of pharmacy in Mississippi. By broadening the scope of practice for pharmacists, it could lead to improved healthcare delivery and patient outcomes, particularly in underserved areas where access to physicians may be limited. Moreover, the bill stipulates that services performed by pharmacists should be reimbursable under health benefit plans, provided that these services fall within the pharmacists' licensed scope of practice and would be reimbursed if conducted by a physician or advanced practice nurse.

Summary

House Bill 1317 is aimed at expanding the role of pharmacists in Mississippi by authorizing them to test for, screen, initiate, and administer treatment for minor, nonchronic health conditions. These conditions are defined in the bill as typically short-term health issues managed with minimal treatment or self-care, including ailments such as influenza, strep throat, and skin conditions such as athletes' foot. The bill recognizes the importance of pharmacists in managing these conditions, potentially enhancing patient access to care and alleviating some of the burdens on primary care physicians.

Contention

Despite its potential benefits, HB1317 may face opposition from various stakeholders, including physicians and healthcare organizations concerned about the implications of expanding pharmacists' responsibilities. There may be debates regarding the adequacy of training pharmacists receive for managing health conditions that are traditionally within the realm of primary care providers. Additionally, issues regarding appropriate reimbursement and the delineation of responsibilities among different healthcare providers could be points of contention.